Ma, Y., Chen, P., Drisko, J. A., Khabele, D., Godwin, A. K., & Chen, Q. (2020). Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP-Ribose) polymerase inhibitors against BRCA1/2 wild-type ovarian cancer. Oncol Lett.
Citação norma ChicagoMa, Yan, Ping Chen, Jeanne A. Drisko, Dineo Khabele, Andrew K. Godwin, and Qi Chen. "Pharmacological Ascorbate Induces ‘BRCAness’ and Enhances the Effects of Poly(ADP-Ribose) Polymerase Inhibitors against BRCA1/2 Wild-type Ovarian Cancer." Oncol Lett 2020.
Citação norma MLAMa, Yan, et al. "Pharmacological Ascorbate Induces ‘BRCAness’ and Enhances the Effects of Poly(ADP-Ribose) Polymerase Inhibitors against BRCA1/2 Wild-type Ovarian Cancer." Oncol Lett 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.